Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Rival Medical Device Companies Battle It Out in Court

Among other things, one business is trying to stop the other from selling a product the FDA has issued warning letters about.

EMED Technologies is seeking a federal court injunction to stop competitor Repro-Med Systems from selling home infusion pumps and needles after the FDA determined the products were adulterated, misbranded and potentially unsafe.

FDA investigators visited the company's Chester, N.Y. facility in June of 2015, where the company was cited for a host of violations. The company responded to many of the violations, and in another warning letter issued in February of this year, the FDA responded to them.

In the meantime, EMED Technologies took matters into their own hands, and filed a suit against their rival company on the basis that an FDA warning letter said the company should "cease activities that result in the misbranding or adulteration of the aforementioned Freedom 60 and Freedom Edge Syringe Infusion Pumps and RMS High-Flo Subcutaneous Safety Needle Sets, such as the commercial distribution of the devices for the uses discussed above."

This not the first time there has been an issue between the two companies.

According to a press release issued by layers for EMED Technologies, the infusion devices, often used at home, include special safety needles, originally developed by inventor Paul Lambert, founder of EMED Technologies.

EMED Technologies filed a patent infringement lawsuit against RMS in Texas last year.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?